Activated CTL traffics and infiltrates into tumor tissues to recognize and kill cancer cells by releasing granzyme and perforin, and ultimately inhibit tumor growth, invasion, and recurrence [25,26]. This evidence concerns the gene PRF1 and neoplasm.